Capital Advisors Ltd’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23K | Buy |
95
+4
| +4% | +$968 | ﹤0.01% | 602 |
|
|
2025
Q1 | $22K | Sell |
91
-3
| -3% | -$725 | ﹤0.01% | 600 |
|
|
2024
Q4 | $31K | Hold |
94
| – | – | ﹤0.01% | 538 |
|
|
2024
Q3 | $31K | Hold |
94
| – | – | ﹤0.01% | 536 |
|
|
2024
Q2 | $26K | Buy |
94
+62
| +194% | +$17.1K | ﹤0.01% | 559 |
|
|
2024
Q1 | $11K | Buy |
32
+1
| +3% | +$344 | ﹤0.01% | 689 |
|
|
2023
Q4 | $10K | Sell |
31
-12
| -28% | -$3.87K | ﹤0.01% | 685 |
|
|
2023
Q3 | $15K | Buy |
43
+12
| +39% | +$4.19K | ﹤0.01% | 602 |
|
|
2023
Q2 | $12K | Sell |
31
-8
| -21% | -$3.1K | ﹤0.01% | 651 |
|
|
2023
Q1 | $19K | Hold |
39
| – | – | ﹤0.01% | 466 |
|
|
2022
Q4 | $16K | Buy |
39
+6
| +18% | +$2.46K | ﹤0.01% | 484 |
|
|
2022
Q3 | $14K | Sell |
33
-1
| -3% | -$424 | ﹤0.01% | 486 |
|
|
2022
Q2 | $17K | Buy |
34
+3
| +10% | +$1.5K | ﹤0.01% | 449 |
|
|
2022
Q1 | $17K | Hold |
31
| – | – | ﹤0.01% | 458 |
|
|
2021
Q4 | $23K | Buy |
+31
| New | +$23K | ﹤0.01% | 419 |
|